TY - JOUR
T1 - Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients
T2 - A prospective study
AU - Son, Heeyoun
AU - Kim, Jeongmee
AU - Kim, Caroline
AU - Ju, Jonathan
AU - Lee, Youngmee
AU - Rhie, Sandy Jeong
N1 - Publisher Copyright:
© 2018 Published by the BMJ Publishing Group Limited.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Objectives Medication reconciliation is a key part of transitional care. This study examined the implementation of a pharmacist-led medication reconciliation programme for short-term hospitalised patients and explored the barriers and benefits. Methods A prospective study was conducted in patients admitted to a gynaecological oncology department. Medications were reconciled on admission using a € comprehensive medication review (CMR)' strategy. Patients received a reminder text message and were asked to bring their medications a day before admission for scheduled chemotherapy. Upon admission, a pharmacist reviewed patients' admission prescriptions and home medications, including non-prescription medications, based on clinical status and laboratory test results. Drug-related problems and unused or expired medications were assessed. Satisfaction with the CMR service and reasons for non-compliance were surveyed by an individual interview. The cost of the unused or expired medications was calculated based on the average drug acquisition cost. Results Sixty-four interventions in 95 patients were performed during the study - namely, correction of treatment duration (34 cases, 53.1%), recommendation of medications for untreated indications (18 cases, 28.1%), correct drug selection (5 cases, 7.8%), discontinuation of duplicate medications (4 cases, 6.3%), correction of dose, provision of alternatives for drug-drug interactions, unintended omissions (1 case each, 1.6%). The difference in the cost of unused or expired drugs before and after programme implementation was about US$1700. Conclusions Pharmacist-led medication reconciliation targeting short-term hospitalised patients improved drug use, prevented medication waste and reduced healthcare costs.
AB - Objectives Medication reconciliation is a key part of transitional care. This study examined the implementation of a pharmacist-led medication reconciliation programme for short-term hospitalised patients and explored the barriers and benefits. Methods A prospective study was conducted in patients admitted to a gynaecological oncology department. Medications were reconciled on admission using a € comprehensive medication review (CMR)' strategy. Patients received a reminder text message and were asked to bring their medications a day before admission for scheduled chemotherapy. Upon admission, a pharmacist reviewed patients' admission prescriptions and home medications, including non-prescription medications, based on clinical status and laboratory test results. Drug-related problems and unused or expired medications were assessed. Satisfaction with the CMR service and reasons for non-compliance were surveyed by an individual interview. The cost of the unused or expired medications was calculated based on the average drug acquisition cost. Results Sixty-four interventions in 95 patients were performed during the study - namely, correction of treatment duration (34 cases, 53.1%), recommendation of medications for untreated indications (18 cases, 28.1%), correct drug selection (5 cases, 7.8%), discontinuation of duplicate medications (4 cases, 6.3%), correction of dose, provision of alternatives for drug-drug interactions, unintended omissions (1 case each, 1.6%). The difference in the cost of unused or expired drugs before and after programme implementation was about US$1700. Conclusions Pharmacist-led medication reconciliation targeting short-term hospitalised patients improved drug use, prevented medication waste and reduced healthcare costs.
KW - comprehensive medication review
KW - gynecologic oncology
KW - hospitalized patients
KW - medication reconciliation
KW - pharmacists
UR - http://www.scopus.com/inward/record.url?scp=85049258873&partnerID=8YFLogxK
U2 - 10.1136/ejhpharm-2016-000937
DO - 10.1136/ejhpharm-2016-000937
M3 - Article
AN - SCOPUS:85049258873
SN - 2047-9956
VL - 25
SP - 21
EP - 25
JO - European Journal of Hospital Pharmacy
JF - European Journal of Hospital Pharmacy
IS - 1
ER -